Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Blind

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 1, 1993
Levels of parathyroid hormone-related protein (PTHrP) in hypercalcemia of malignancy are not lowered by treatment with the bisphosphonate BM 21.0955E Blind, F Raue, T Meinel, et al.
Medizinische Klinik (Munich, Germany : 1983)|September 15, 1992
[Parathyrotoxic crisis with fatal outcome--what can be learned from this?]F Raue, E Blind, G Schuler, et al.
Experimental and Clinical Endocrinology|January 1, 1993
Cyclic AMP formation in rat bone and kidney cells is stimulated equally by parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34E Blind, F Raue, V Knappe, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 1, 1996
Phosphorylation of the cytoplasmic tail of the PTH/PTHrP receptorE Blind, T Bambino, Z Huang, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1993
Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancyT Schilling, M Pecherstorfer, E Blind, et al.
Applied Biosafety : Journal of the American Biological Safety Association|August 29, 2022
Biosafety Practices for In Vivo Viral-Mediated Gene Therapy in the Health Care SettingJill E Blind, E Nicole McLeod, Alex Brown, et al.
Journal of the Pediatric Infectious Diseases Society|October 6, 2022
Implementation and Patient Outcomes of a Pediatric COVID-19 Monoclonal Antibody ProgramJill E Blind, Matt Sapko, Alex Killough, et al.
Deutsche Medizinische Wochenschrift (1946)|May 28, 2003
[Severe Vitamin D(dihydrotachysterol)-intoxication with temporary anemia and hypercalcemia responsive to bisphosphonates]E Blind, M Fassnacht, C Körber, et al.
Clinical Chemistry|February 1, 1989
Two-site immunochemiluminometric assay of intact human parathyrin in serum with use of a tracer peptide purified by reversed-phase high-performance liquid chromatographyU Böhler, E Blind, G Vogel, et al.
Clinical Endocrinology|September 1, 1992
Circulating levels of midregional parathyroid hormone-related protein in hypercalcaemia of malignancyE Blind, F Raue, J Götzmann, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 1, 1993
Levels of parathyroid hormone-related protein (PTHrP) in hypercalcemia of malignancy are not lowered by treatment with the bisphosphonate BM 21.0955E Blind, F Raue, T Meinel, et al.
Medizinische Klinik (Munich, Germany : 1983)|September 15, 1992
[Parathyrotoxic crisis with fatal outcome--what can be learned from this?]F Raue, E Blind, G Schuler, et al.
Experimental and Clinical Endocrinology|January 1, 1993
Cyclic AMP formation in rat bone and kidney cells is stimulated equally by parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34E Blind, F Raue, V Knappe, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 1, 1996
Phosphorylation of the cytoplasmic tail of the PTH/PTHrP receptorE Blind, T Bambino, Z Huang, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1993
Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancyT Schilling, M Pecherstorfer, E Blind, et al.
Applied Biosafety : Journal of the American Biological Safety Association|August 29, 2022
Biosafety Practices for In Vivo Viral-Mediated Gene Therapy in the Health Care SettingJill E Blind, E Nicole McLeod, Alex Brown, et al.
Journal of the Pediatric Infectious Diseases Society|October 6, 2022
Implementation and Patient Outcomes of a Pediatric COVID-19 Monoclonal Antibody ProgramJill E Blind, Matt Sapko, Alex Killough, et al.
Deutsche Medizinische Wochenschrift (1946)|May 28, 2003
[Severe Vitamin D(dihydrotachysterol)-intoxication with temporary anemia and hypercalcemia responsive to bisphosphonates]E Blind, M Fassnacht, C Körber, et al.
Clinical Chemistry|February 1, 1989
Two-site immunochemiluminometric assay of intact human parathyrin in serum with use of a tracer peptide purified by reversed-phase high-performance liquid chromatographyU Böhler, E Blind, G Vogel, et al.
Clinical Endocrinology|September 1, 1992
Circulating levels of midregional parathyroid hormone-related protein in hypercalcaemia of malignancyE Blind, F Raue, J Götzmann, et al.
Pageof 5